Cannara Biotech Inc.
LOVFFOTCHealthcare● Active
$1.20
+$0.00(+0.16%)
Market Cap$118736142
P/E Ratio—
52W High$1.47
52W Low$0.81222
Cannara Biotech Inc.（LOVFF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LOVFF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-08 | 2024-08 | 2023-08 | 2022-08 | 2021-08 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.11B | $0.08B | $0.06B | $0.04B | $0.02B |
| Cost of Revenue | $0.06B | $0.05B | $0.03B | $0.02B | $0.01B |
| Gross Profit | $0.05B | $0.03B | $0.03B | $0.02B | $0.01B |
| Gross Margin %(computed) | 44.00% | 36.44% | 47.56% | 48.36% | 60.50% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Total Operating Expenses | $0.03B | $0.02B | $0.02B | $0.01B | $0.01B |
| Operating Income | $0.02B | $0.01B | $0.01B | $0.00B | $0.00B |
| Operating Margin %(computed) | 20.68% | 12.33% | 20.76% | 13.78% | 1.51% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.02B | $0.00B | $0.01B | $0.00B | ($0.00B) |
| Income Tax Expense | $0.01B | ($0.00B) | $0.00B | $0.00B | $0.00B |
| Net Income | $0.01B | $0.01B | $0.01B | $0.00B | ($0.00B) |
| Net Margin %(computed) | 12.18% | 7.88% | 12.13% | 6.43% | -8.98% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.14 | $0.06 | $0.08 | $0.03 | $-0.02 |
| Wtd Avg Shares | 0.09B | 0.10B | 0.09B | 0.09B | 0.08B |
| EBITDA | $0.03B | $0.02B | $0.02B | $0.01B | $0.00B |
| EBITDA Margin %(computed) | 26.26% | 18.55% | 27.54% | 23.43% | 18.00% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · CAD · B
深入了解Cannara Biotech Inc.
关于Cannara Biotech Inc.（LOVFF）损益表
Cannara Biotech Inc.（LOVFF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，LOVFF实现营收$0.11B，毛利润$0.05B（毛利率44.00%），净利润$0.01B（净利率12.18%）。
常见问题
LOVFF · 4 问Cannara Biotech Inc.（LOVFF）2025财年营收为$0.11B，同比up31.3%。
LOVFF revenueLOVFF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09